MNKD Q1 2024 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$66M+63.1% YoY

Gross Profit

$48M71.9% margin

Operating Income

$17M25.2% margin

Net Income

$11M16.0% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+13.3%

Cash Flow

Operating Cash Flow

$7M

Free Cash Flow

$4M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$481M

Total Liabilities

$711M

Stockholders' Equity

-$230M

Cash & Equivalents

$193M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66M	$41M	+63.1%
Gross Profit	$48M	$24M	+95.2%
Operating Income	$17M	-$6M	+378.8%
Net Income	$11M	-$10M	+208.5%

Revenue Segments

License And Service

$15M100%